Works matching IS 0167594X AND DT 2016 AND VI 129 AND IP 3
Results: 24
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 443, doi. 10.1007/s11060-016-2189-7
- By:
- Publication type:
- Article
Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 453, doi. 10.1007/s11060-016-2190-1
- By:
- Publication type:
- Article
Does the choice of antiepileptic drug affect survival in glioblastoma patients?
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 461, doi. 10.1007/s11060-016-2191-0
- By:
- Publication type:
- Article
The incidence and significance of multicentric noncontrast-enhancing lesions distant from a histologically-proven glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 471, doi. 10.1007/s11060-016-2193-y
- By:
- Publication type:
- Article
Age alone is not a predictor for survival in glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 479, doi. 10.1007/s11060-016-2194-x
- By:
- Publication type:
- Article
A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 487, doi. 10.1007/s11060-016-2195-9
- By:
- Publication type:
- Article
Rapid progression of intracranial melanoma metastases controlled with combined BRAF/MEK inhibition after discontinuation of therapy: a clinical challenge.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 389, doi. 10.1007/s11060-016-2196-8
- By:
- Publication type:
- Article
SHP-1 promoter 2 methylation in cerebrospinal fluid for diagnosis of leptomeningeal epithelial-derived malignancy (carcinomatous meningitis).
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 395, doi. 10.1007/s11060-016-2199-5
- By:
- Publication type:
- Article
The clinical significance of fascin expression in a newly diagnosed primary glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 495, doi. 10.1007/s11060-016-2200-3
- By:
- Publication type:
- Article
Utility of MRI versus tumor markers for post-treatment surveillance of marker-positive CNS germ cell tumors.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 541, doi. 10.1007/s11060-016-2207-9
- By:
- Publication type:
- Article
Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 505, doi. 10.1007/s11060-016-2201-2
- By:
- Publication type:
- Article
Coexistence of MLH3 germline variants in colon cancer patients belonging to families with Lynch syndrome-associated brain tumors.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 525, doi. 10.1007/s11060-016-2204-z
- By:
- Publication type:
- Article
Expression of p40 (∆Np63) protein in meningiomas, an unexpected finding: immunohistochemical study and evaluation of its possible prognostic role.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 405, doi. 10.1007/s11060-016-2205-y
- By:
- Publication type:
- Article
Impact of tapering and discontinuation of bevacizumab in patients with progressive glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 533, doi. 10.1007/s11060-016-2206-x
- By:
- Publication type:
- Article
Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 515, doi. 10.1007/s11060-016-2202-1
- By:
- Publication type:
- Article
A cure is possible: a study of 10-year survivors of brain metastases.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 545, doi. 10.1007/s11060-016-2208-8
- By:
- Publication type:
- Article
Low expressions of ASS1 and OTC in glioblastoma suggest the potential clinical use of recombinant human arginase (rhArg).
- Published in:
- 2016
- By:
- Publication type:
- Letter
Anaplastic astrocytoma: prognostic factors and survival in 4807 patients with emphasis on receipt and impact of adjuvant therapy.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 557, doi. 10.1007/s11060-016-2210-1
- By:
- Publication type:
- Article
Application of brush cytology for FISH-based detection of 1p/19q codeletion in oligodendroglial tumors.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 415, doi. 10.1007/s11060-016-2211-0
- By:
- Publication type:
- Article
Utilization and impact of adjuvant therapy in anaplastic oligodendroglioma: an analysis on 1692 patients.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 567, doi. 10.1007/s11060-016-2212-z
- By:
- Publication type:
- Article
Mir-449a, a potential diagnostic biomarker for WNT group of medulloblastoma.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 423, doi. 10.1007/s11060-016-2213-y
- By:
- Publication type:
- Article
The effects of sequential treatments on hippocampal volumes in malignant glioma patients.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 433, doi. 10.1007/s11060-016-2188-8
- By:
- Publication type:
- Article
Rapid progression of intracranial melanoma metastases controlled with combined BRAF/MEK inhibition after discontinuation of therapy: a clinical challenge.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 389, doi. 10.1007/s11060-016-2196-8
- By:
- Publication type:
- Article